Some evidence suggests a higher risk of liver disease with psoriasis. Certain psoriasis treatments can cause liver toxicity, but the two conditions also share common risk factors, which may ...

The value of silymarin in the treatment of psoriasis may be due to its ability to improve endotoxin removal by the liver, inhibit cAMP phosphodiesterase, and inhibit leukotriene synthesis.

It’s made, and usually found, in your liver. The University of Bath ... suggests hepcidin would be a good target for skin ...

The researchers highlighted that psoriasis is a systemic condition linked to various comorbidities, emphasizing the ...

Two new medicines have been approved to help treat prostate and liver cancer patients in Scotland. The Scottish Medicines Consortium (SMC) announced it had recommended two treatments for the diseases.

The psoriasis market is estimated to reach ... is designed to address multi-billion-dollar markets in the treatment of cancer, liver, and inflammatory disease. The Company’s lead drug candidate ...

Medical University of Vienna. (2025, March 3). New treatment option for psoriasis discovered. ScienceDaily. Retrieved March 23, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250303141858.htm ...

Patients with psoriasis taking a systemic therapy drug like methotrexate (under brand names like Trexall, Rasuvo, and Otrexup PF), had the highest risk, particularly for non-alcoholic fatty liver ...

Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still requires a good multidisciplinary team, like any cancer treatment ...

This study of the efficacy and cost-effectiveness of moderate to severe psoriasis treatments compared phototherapy, oral systemic agents, and biologics from a managed health care systems perspective.